We describe pronounced hypotension in a patient during orthostatic testing while receiving treatment with sildenafil and tamsulosin, but not with placebo. The patient was 71 years of age and had ...

New data have prompted calls for the safety information provided with tamsulosin tablets to be reassessed. Blockade of α 1a-adrenergic receptors in the smooth muscle of the prostate and bladder ...

Specifically for the DUT + TAM FDC vs. tamsulosin monotherapy, economic analyses have been conducted in the UK, [10] Canada, [11] Spain, [12] and Scandinavia, [13] where the fixed-dose ...

These vascular effects can, however, be greatly reduced by the use of the α 1a receptor antagonist tamsulosin, which specifically targets urothelial smooth muscle. α-Blockers are not yet ...